Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
8,718 total articles
Northrop Grumman ($NOC) trades below obvious re-rating levels for a defense prime with strong free cash flow, improving backlog exposure to space and integrated battle command systems, and a manageable balance sheet. With an enterprise value near $107.1B and free cash flow roughly $3.3B, I see a mid-term trade to capture program execution upside as…
Inspired Entertainment (INSE) offers an asymmetric setup: entrenched gaming and virtual-sports products, recent technical support and upbeat momentum, and a sub-$1x price-to-sales multiple that leaves upside if Strata and interactive revenues accelerate. We layout an actionable mid-term trade with precise entry, stop and target.
Intel is positioned to capture a material slice of renewed CPU-led AI demand while launching competitively priced workstation GPUs and expanding foundry services. At $43.49 and a market cap near $217B, the stock offers asymmetric upside if AI-driven pricing power and product wins translate to positive cash flow. This is a conviction swing trade: en…
Porch Group (PRCH) is trading well below its 52-week high after a pullback. With a $717M market cap, $52M in trailing free cash flow, and improving top-line momentum after recent beats, a targeted long into a Texas expansion narrative offers asymmetric upside over the next 180 trading days. This trade idea lays out entry, stop and a two-stage targe…
Coinbase is trading near $166 after a painful multi-quarter drawdown, but recent product wins - notably the Fannie Mae-backed crypto mortgage pilot and continued growth in onchain product revenue - materially change the company's optionality. We upgrade to a buy and lay out a long-term trade (180 trading days) with a clear entry at $166.05, a stop …
Q32 Bio's small-cap rerating since the ADX-097 asset sale has left bempikibart as the focal point for upside. With a market cap near $107M, low float, positive technicals and clear upcoming catalysts, a mid-term long trade offers asymmetric upside if clinical announcements remain constructive. Tight risk management is essential given binary clinica…
Celsius (CELH) has pulled back sharply into oversold territory even as 2025 revenue surged to a record $2.5 billion and strategic acquisitions (Alani Nu, Rockstar) materially accelerate growth. The pullback after competitor noise (Costco private label) presents a trade-able long: enter near $34.86, stop $30.00, target $52.00 on a 180-trading-day ho…
Novo Nordisk (NVO) has pulled back from 2025 highs and now trades near its 52-week low after a period of heavy multiple compression. The FDA approval of Awiqli (weekly basal insulin) on 03/27/2026 is a substantial fundamental catalyst that can reaccelerate growth and offset headline risk. With a market cap of $162.7B, a P/E of 10.34 and a dividend …
Coeur Mining (CDE) has retraced sharply despite stronger cash flow, a manageable balance sheet and a meaningful production boost from the New Gold acquisition. A tactical long at $17.50 with a $15.90 stop targets $22.00 over the next ~45 trading days, playing for a recovery to the 50-day technical band and re-rating driven by buybacks, dividend ini…
Aptiv trades at an attractive enterprise-value-to-sales and EV/EBITDA multiple while sitting squarely in markets (ADAS, VCUs, vehicle electrification, software-defined vehicles) growing at double-digit rates. Technicals show oversold momentum and short interest is manageable. This trade plan buys the current weakness with a clear stop and a 180-tra…
PROCEPT BioRobotics (PRCT) is a commercial-stage surgical robotics company focused on Aquablation for BPH. The stock trades at $26.49 with a $1.49B market cap after a February guidance cut and a subsequent wave of negative headlines. Fundamentals show rapid prior top-line growth, a strong liquidity position, and an EV/sales ratio that can compress …
Samsara just proved it can grow into profitability while moving deeper into large-enterprise accounts. With $1.89B ARR, accelerating $100K+ customer mix, and two consecutive GAAP profitable quarters, the company is trading at an attractive risk/reward for a long trade. Entry $30.00, target $42.00, stop $26.00 — long term (180 trading days).
Monarch Cement (MCEM) has already delivered a nice run from its 2025 low, but the company’s sub-$1B market cap, modest PE of 14.3, and concrete exposure to U.S. infrastructure spending leave a constructive setup. The trade is long with defined risk - target near the 52-week high and a stop below structurally important support. Liquidity is low and …
Alphabet's recent model-quantization work is often read as reducing hardware needs. That's a surface-level take. TurboQuant lowers per-inference cost, which accelerates adoption and utilization of large models in production — a dynamic that increases demand for high-bandwidth memory and premium SSDs. Micron has mass-produced HBM4, posted blockbuste…
Kimbell Royalty Partners (KRP) trades near $14.70 with a projected average 2026 quarterly distribution of $0.47 per unit (annualized $1.88), implying a cash yield in the low double-digits. The company’s royalty model, low maintenance capex and healthy cash flow profile make KRP an attractive income trade. This idea presents a long trade with entry …
Fastly reported a clear earnings inflection in Q4 and issued aggressive 2026 guidance. If the company converts AI edge traffic into sustainable operating leverage and narrows margin gaps with larger peers, its current EV/Sales near 7x looks conservative. This trade targets a re-rating to ~9x EV/Sales on 2026 revenue guidance, with a clear entry, st…
Zhihu (ZH) is trading near its 52-week low after an AI-led re-rating of knowledge platforms. The company has shown non-GAAP profitability in recent quarters and trades at a low market cap and sub-1 P/B. That setup creates a tradeable asymmetric opportunity: a disciplined long with a tight stop that targets a reversion toward mid-cycle multiples if …
Goldman Sachs BDC (GSBD) offers a double-digit yield and trades at a steep price-to-book discount. But weak technicals, rising short interest, high leverage and continued private-credit pressures argue the market may be underestimating downside. This is a tactical short idea with clearly defined entry, stop and target for a mid-term (45 trading day…
Micron's recent pullback has compressed expectations and priced in inventory risk. For disciplined traders, this is an actionable long: buy the dip into secular DRAM/NAND demand from AI and data-center upgrades while using a tight stop to manage cycle risk.
Scorpio Tankers (STNG) offers a pragmatic long trade into 2026 anchored on recent vessel sales, multi-year time charters at strong rates, and a recovery in market pricing. At a $3.92B market cap and a P/E near 10, the stock has room to rerate if freight markets remain resilient. Trade plan provided with entry, stop, and target alongside risks and a…
Match Group (MTCH) is trading at a notable discount to its cash-generation profile. With roughly $1.02B in free cash flow on a market cap of ~$6.9B (implying an FCF yield near 15%), a P/E around 11-12 and EV/EBITDA under 10, the stock looks materially undervalued for a stable, high-margin consumer internet business. Index-related selling and short-…
Micron's recent pullback appears driven more by algorithmic headlines (TurboQuant, Sora) and momentum trading than by a durable break in fundamentals. With Q2 fiscal strength, tight memory supply, meaningful FCF and a reasonable P/E, this is a tactical buy with a clear stop and a mid-term target sized to the company's growth runway.
Microsoft shares have been hit hard this year but the business fundamentals and cash generation remain strong. With RSI at ~22 and trading near the 52-week low, this trade idea targets a mean-reversion back toward the $410 area while keeping a tight stop below the recent low. The trade balances near-term technical recovery with longer-term secular …
Zoom ($ZM) is trading at roughly 12x reported earnings with $1.9B in annual free cash flow, a clean balance sheet and double-digit return on equity. Recent multiple compression and a muted reaction to improving fundamentals have created a tradeable risk/reward: enter at $77.72, stop $70.00, target $95.00 over a long-term (180 trading days) horizon.
Conagra is trading near its 52-week low at $15.64 with an 8.95% yield, P/FCF ~8.5 and EV/EBITDA 9.35. Fundamentals are mixed, but the market is pricing in a prolonged recovery. For income and value-oriented traders willing to wait up to 180 trading days, this looks like a high-expected-value long trade with defined risk-management.
